150 related articles for article (PubMed ID: 37309675)
1. The enzymatic and neurochemical outcomes of a mutation in Mexican cavefish MAO reveal teleost-specific aspects of brain monoamine homeostasis.
Pierre C; Callebert J; Launay JM; Leclercq J; Rétaux S
J Exp Biol; 2023 Jul; 226(14):. PubMed ID: 37309675
[TBL] [Abstract][Full Text] [Related]
2. A mutation in monoamine oxidase (MAO) affects the evolution of stress behavior in the blind cavefish
Pierre C; Pradère N; Froc C; Ornelas-García P; Callebert J; Rétaux S
J Exp Biol; 2020 Sep; 223(Pt 18):. PubMed ID: 32737213
[TBL] [Abstract][Full Text] [Related]
3. An Astyanax mexicanus mao knockout line uncovers the developmental roles of monoamine homeostasis in fish brain.
Alunni A; Pierre C; Torres-Paz J; Clairet N; Langlumé A; Pavie M; Escoffier-Pirouelle T; Leblanc M; Blin M; Rétaux S
Dev Growth Differ; 2023 Dec; 65(9):517-533. PubMed ID: 37843474
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the enzyme monoamine oxidase explains part of the Astyanax cavefish behavioural syndrome.
Elipot Y; Hinaux H; Callebert J; Launay JM; Blin M; Rétaux S
Nat Commun; 2014 Apr; 5():3647. PubMed ID: 24717983
[TBL] [Abstract][Full Text] [Related]
5. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
Geha RM; Rebrin I; Chen K; Shih JC
J Biol Chem; 2001 Mar; 276(13):9877-82. PubMed ID: 11134050
[TBL] [Abstract][Full Text] [Related]
6. Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos.
Wang CC; Man GC; Chu CY; Borchert A; Ugun-Klusek A; Billett EE; Kühn H; Ufer C
J Biol Chem; 2014 Mar; 289(12):8252-63. PubMed ID: 24497636
[TBL] [Abstract][Full Text] [Related]
7. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
Nandigama RK; Miller JR; Edmondson DE
Biochemistry; 2001 Dec; 40(49):14839-46. PubMed ID: 11732903
[TBL] [Abstract][Full Text] [Related]
8. Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish.
Baronio D; Chen YC; Panula P
Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 34881779
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA
J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932
[TBL] [Abstract][Full Text] [Related]
10. NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Matošić A; Marušić S; Vidrih B; Kovak-Mufić A; Cicin-Šain L
Acta Clin Croat; 2016 Mar; 55(1):134-50. PubMed ID: 27333729
[TBL] [Abstract][Full Text] [Related]
11. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
12. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of an evolutionary precursor of human monoamine oxidases A and B.
Sablin SO; Yankovskaya V; Bernard S; Cronin CN; Singer TP
Eur J Biochem; 1998 Apr; 253(1):270-9. PubMed ID: 9578486
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidases in development.
Wang CC; Billett E; Borchert A; Kuhn H; Ufer C
Cell Mol Life Sci; 2013 Feb; 70(4):599-630. PubMed ID: 22782111
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor design for monoamine oxidases.
Ramsay RR
Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Metabolic Trapping Radiotracers for Imaging Monoamine Oxidase-A and -B Enzymatic Activity.
Brooks AF; Shao X; Quesada CA; Sherman P; Scott PJ; Kilbourn MR
ACS Chem Neurosci; 2015 Dec; 6(12):1965-71. PubMed ID: 26393369
[TBL] [Abstract][Full Text] [Related]
17. Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice.
Owesson CA; Hopwood SE; Callado LF; Seif I; McLaughlin DP; Stamford JA
Eur J Neurosci; 2002 May; 15(9):1516-22. PubMed ID: 12028362
[TBL] [Abstract][Full Text] [Related]
18. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
Naoi M; Riederer P; Maruyama W
J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
20. Effects of carboxyl-terminal truncations on the activity and solubility of human monoamine oxidase B.
Rebrin I; Geha RM; Chen K; Shih JC
J Biol Chem; 2001 Aug; 276(31):29499-506. PubMed ID: 11371556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
